3-42407142-T-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_144634.4(LYZL4):​c.110A>T​(p.Asp37Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000409 in 1,614,068 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00024 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000020 ( 0 hom. )

Consequence

LYZL4
NM_144634.4 missense

Scores

3
2
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.568
Variant links:
Genes affected
LYZL4 (HGNC:28387): (lysozyme like 4) Lysozymes (see LYZ; MIM 153450), especially C-type lysozymes, are well-recognized bacteriolytic factors widely distributed in the animal kingdom and play a mainly protective role in host defense. LYZL4 is a member of a family of lysozyme-like genes (Zhang et al., 2005 [PubMed 16014814]).[supplied by OMIM, Apr 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.12048522).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
LYZL4NM_144634.4 linkuse as main transcriptc.110A>T p.Asp37Val missense_variant 2/5 ENST00000287748.8
LYZL4NM_001304386.2 linkuse as main transcriptc.110A>T p.Asp37Val missense_variant 2/5
LYZL4XM_011533355.4 linkuse as main transcriptc.110A>T p.Asp37Val missense_variant 2/5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
LYZL4ENST00000287748.8 linkuse as main transcriptc.110A>T p.Asp37Val missense_variant 2/51 NM_144634.4 P1
LYZL4ENST00000441172.1 linkuse as main transcriptc.110A>T p.Asp37Val missense_variant 2/55 P1
LYZL4ENST00000470991.1 linkuse as main transcriptn.140A>T non_coding_transcript_exon_variant 2/53

Frequencies

GnomAD3 genomes
AF:
0.000243
AC:
37
AN:
152058
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000749
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000328
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000479
GnomAD3 exomes
AF:
0.0000358
AC:
9
AN:
251436
Hom.:
0
AF XY:
0.0000294
AC XY:
4
AN XY:
135888
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000198
AC:
29
AN:
1461892
Hom.:
0
Cov.:
33
AF XY:
0.0000179
AC XY:
13
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.000657
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000993
GnomAD4 genome
AF:
0.000243
AC:
37
AN:
152176
Hom.:
0
Cov.:
32
AF XY:
0.000134
AC XY:
10
AN XY:
74410
show subpopulations
Gnomad4 AFR
AF:
0.000746
Gnomad4 AMR
AF:
0.000327
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000474
Alfa
AF:
0.000260
Hom.:
0
Bravo
AF:
0.000268
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000494
AC:
6

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 18, 2021The c.110A>T (p.D37V) alteration is located in exon 2 (coding exon 1) of the LYZL4 gene. This alteration results from a A to T substitution at nucleotide position 110, causing the aspartic acid (D) at amino acid position 37 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
20
DANN
Uncertain
0.98
DEOGEN2
Benign
0.22
T;T
Eigen
Benign
-0.56
Eigen_PC
Benign
-0.82
FATHMM_MKL
Benign
0.038
N
LIST_S2
Benign
0.78
.;T
M_CAP
Benign
0.077
D
MetaRNN
Benign
0.12
T;T
MetaSVM
Benign
-0.55
T
MutationAssessor
Pathogenic
3.3
M;M
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.32
T
PROVEAN
Pathogenic
-6.6
D;D
REVEL
Benign
0.24
Sift
Pathogenic
0.0
D;D
Sift4G
Uncertain
0.0030
D;D
Polyphen
0.91
P;P
Vest4
0.26
MVP
0.76
MPC
0.71
ClinPred
0.50
T
GERP RS
-3.3
Varity_R
0.44
gMVP
0.78

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs143954677; hg19: chr3-42448634; API